ALGS
Price
$9.90
Change
+$0.24 (+2.48%)
Updated
Nov 26, 04:59 PM (EDT)
Capitalization
60.92M
Intraday BUY SELL Signals
RGNX
Price
$13.24
Change
-$0.21 (-1.56%)
Updated
Nov 26, 04:59 PM (EDT)
Capitalization
670.5M
97 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALGS vs RGNX

Header iconALGS vs RGNX Comparison
Open Charts ALGS vs RGNXBanner chart's image
Aligos Therapeutics
Price$9.90
Change+$0.24 (+2.48%)
Volume$100
Capitalization60.92M
REGENXBIO
Price$13.24
Change-$0.21 (-1.56%)
Volume$25.39K
Capitalization670.5M
ALGS vs RGNX Comparison Chart in %
ALGS
Daily Signal:
Gain/Loss:
RGNX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ALGS vs. RGNX commentary
Nov 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGS is a StrongBuy and RGNX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 27, 2025
Stock price -- (ALGS: $9.66 vs. RGNX: $13.45)
Brand notoriety: ALGS and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALGS: 103% vs. RGNX: 161%
Market capitalization -- ALGS: $60.92M vs. RGNX: $670.5M
ALGS [@Biotechnology] is valued at $60.92M. RGNX’s [@Biotechnology] market capitalization is $670.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $109.65B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGS’s FA Score shows that 1 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • ALGS’s FA Score: 1 green, 4 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, RGNX is a better buy in the long-term than ALGS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGS’s TA Score shows that 4 TA indicator(s) are bullish while RGNX’s TA Score has 4 bullish TA indicator(s).

  • ALGS’s TA Score: 4 bullish, 6 bearish.
  • RGNX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, RGNX is a better buy in the short-term than ALGS.

Price Growth

ALGS (@Biotechnology) experienced а +21.97% price change this week, while RGNX (@Biotechnology) price change was +19.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.60%. For the same industry, the average monthly price growth was -1.29%, and the average quarterly price growth was +72.73%.

Reported Earning Dates

RGNX is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+4.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGNX($671M) has a higher market cap than ALGS($60.9M). RGNX YTD gains are higher at: 73.997 vs. ALGS (-75.753). ALGS has higher annual earnings (EBITDA): -75.81M vs. RGNX (-129.93M). RGNX has more cash in the bank: 323M vs. ALGS (123M). ALGS has less debt than RGNX: ALGS (6.88M) vs RGNX (77.7M). RGNX has higher revenues than ALGS: RGNX (156M) vs ALGS (3.17M).
ALGSRGNXALGS / RGNX
Capitalization60.9M671M9%
EBITDA-75.81M-129.93M58%
Gain YTD-75.75373.997-102%
P/E RatioN/AN/A-
Revenue3.17M156M2%
Total Cash123M323M38%
Total Debt6.88M77.7M9%
FUNDAMENTALS RATINGS
RGNX: Fundamental Ratings
RGNX
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
17
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALGSRGNX
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 7 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ALGS
Daily Signal:
Gain/Loss:
RGNX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NMIEX13.700.17
+1.26%
Northern Active M International Equity
ISTIX91.860.90
+0.99%
Macquarie Science and Technology I
HSMSX12.96N/A
N/A
Hartford Small Cap Value R4
MSCGX11.64N/A
N/A
Mercer US Small/Mid Cap Equity Y3
FSZZX11.45N/A
N/A
Fidelity Advisor Sustainable EM Eq Z

ALGS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGS has been loosely correlated with ARWR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGS jumps, then ARWR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGS
1D Price
Change %
ALGS100%
+1.52%
ARWR - ALGS
46%
Loosely correlated
+5.72%
SYRE - ALGS
45%
Loosely correlated
+8.27%
XNCR - ALGS
44%
Loosely correlated
+3.11%
BEAM - ALGS
43%
Loosely correlated
+4.53%
RGNX - ALGS
41%
Loosely correlated
+9.98%
More

RGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGNX has been loosely correlated with SYRE. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if RGNX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGNX
1D Price
Change %
RGNX100%
+9.98%
SYRE - RGNX
57%
Loosely correlated
+8.27%
BEAM - RGNX
55%
Loosely correlated
+4.53%
DNLI - RGNX
55%
Loosely correlated
+1.06%
KYMR - RGNX
54%
Loosely correlated
+0.69%
RXRX - RGNX
54%
Loosely correlated
+0.92%
More